指南与共识间质性肺疾病

家族性肺纤维化:英国关于患者及亲属调查与管理的共识框架

Familial pulmonary fibrosis: a UK consensus framework for the investigation and management of patients and their relatives.
指南 / 共识 · Thorax · 2026-09-10

该英国共识探讨家族性肺纤维化的病因与临床特征,提出遗传学调查和临床管理框架。建议初始评估识别单基因病患者,关注端粒或表面活性物质生物学异常的病史与检查要点,强调遗传诊断对多学科管理和亲属筛查的价值,并提出标准化诊疗路径以建立国家数据库。

要点

  • 成人起病单基因病多由端粒维持功能障碍所致,少数由表面活性物质生物学异常引起。
  • 遗传诊断有助于多学科管理并促进对近亲家属的筛查。
  • 共识提出家族性肺纤维化患者及亲属的调查与管理路径。

核心结论

  • 共识提出家族性肺纤维化患者及亲属的调查与管理路径,旨在标准化临床照护并建立国家数据库以促进疾病表型分析和临床研究。

研究设计与样本

  • 英国共识框架,针对家族性肺纤维化的病因、临床特征、遗传学调查及患者和亲属的临床管理提出建议。

主要发现

  • 成人起病单基因病最常见于端粒维持功能障碍,小部分由表面活性物质生物学异常所致。
  • 这些疾病可伴需监测或治疗的其他肺内和肺外特征,使遗传诊断变得重要。
  • 临床与影像表现多样,遗传诊断可指导多学科管理并促进对近亲家属的筛查。
  • 存在许多未确定性和挑战,包括非单基因家族性肺纤维化的调查与管理,以及携带潜在致病遗传变异无症状家属的管理。

关键数值与推荐

  • 建议初始评估以帮助识别单基因病患者,重点关注病史和检查中可能提示端粒或表面活性物质生物学异常的关键点。

临床怎么用

  • 对家族性肺纤维化患者进行初始评估以识别单基因病线索,并考虑遗传诊断以指导多学科管理和近亲筛查。

局限性

  • 非单基因家族性肺纤维化的调查与管理存在未确定性。
  • 携带潜在致病遗传变异无症状家属的管理存在挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: There is a growing recognition that genetic predisposition contributes to the development of fibrotic interstitial lung disease. Adult onset monogenic disease is most commonly due to dysfunctional telomere maintenance, with a small proportion caused by surfactant biology disorders. These conditions can be associated with additional intrapulmonary and extrapulmonary features which themselves may require surveillance or treatment, making it important to make a genetic diagnosis. The recent introduction in England of a genetic testing panel accessible to respiratory physicians means that genetic information for these individuals is increasingly available but there is currently little standardisation of the subsequent management of patients and their relatives, which can be complex.Aims: This consensus considers the causes and clinical features of familial pulmonary fibrosis and provides a suggested framework for genetic investigation and clinical management of both patients and their relatives.Narrative: We suggest an initial workup that may help identify those with monogenic disease, with focus on key points in the history and examination that may identify features of a telomere or surfactant biology disorder. We highlight that clinical and radiological presentations are diverse and discuss the importance of making a genetic diagnosis to inform multidisciplinary management and facilitate screening of close family members. We also discuss the many outstanding uncertainties and challenges, including the investigation and management of non-monogenic familial pulmonary fibrosis and the management of asymptomatic family members who have inherited a potentially disease-causing genetic variant.Conclusions: We suggest a pathway for the workup and management of patients with familial pulmonary fibrosis, aiming to standardise clinical care for patients and their relatives and provide a framework for the development of a national database to facilitate disease phenotyping and clinical research to improve the evidence base for clinical practice.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Bowden AR, Morris-Rosendahl DJ, Hanson H, et al. Familial pulmonary fibrosis: a UK consensus framework for the investigation and management of patients and their relatives. Thorax. 2026. PMID: 42722421. doi:10.1136/thorax-2026-225625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。